Cargando…
Therapeutic Applications of Azanucleoside Analogs as DNA Demethylating Agents
Azanucleosides, such as 5-azacytidine and decitabine, are DNA demethylating agents used in the treatment of acute myeloid leukemia and myelodysplastic syndromes. Researchers continue to explore their utility in the treatment of other hematologic and solid tumors. Based on the capacity of the compoun...
Autores principales: | Gallimore, Fallon, Fandy, Tamer E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366911/ https://www.ncbi.nlm.nih.gov/pubmed/37489400 http://dx.doi.org/10.3390/epigenomes7030012 |
Ejemplares similares
-
How Azanucleosides Affect Myeloid Cell Fate
por: Stein, Anna, et al.
Publicado: (2022) -
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers
por: Diesch, Jeannine, et al.
Publicado: (2016) -
Efficient diastereoselective synthesis of a new class of azanucleosides: 2′-homoazanucleosides
por: Bouton, Jakob, et al.
Publicado: (2017) -
Pulmonary Complications of Azanucleoside Therapy in Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia
por: Molina, Manuel, et al.
Publicado: (2015) -
Demethylating Agents in the Treatment of Cancer
por: Howell, Paul M., et al.
Publicado: (2010)